Tempest Therapeutics Management
Management criteria checks 2/4
Tempest Therapeutics' CEO is Steve Brady, appointed in Jun 2021, has a tenure of 3.42 years. total yearly compensation is $7.01M, comprised of 8.1% salary and 91.9% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth $41.99K. The average tenure of the management team and the board of directors is 3.3 years and 3.4 years respectively.
Key information
Steve Brady
Chief executive officer
US$7.0m
Total compensation
| CEO salary percentage | 8.1% |
| CEO tenure | 3.4yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.4yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$36m |
| Jun 30 2024 | n/a | n/a | -US$32m |
| Mar 31 2024 | n/a | n/a | -US$30m |
| Dec 31 2023 | US$7m | US$567k | -US$29m |
| Sep 30 2023 | n/a | n/a | -US$31m |
| Jun 30 2023 | n/a | n/a | -US$33m |
| Mar 31 2023 | n/a | n/a | -US$35m |
| Dec 31 2022 | US$2m | US$530k | -US$36m |
| Sep 30 2022 | n/a | n/a | -US$34m |
| Jun 30 2022 | n/a | n/a | -US$34m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$715k | US$475k | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$25m |
| Jun 30 2021 | n/a | n/a | -US$22m |
| Mar 31 2021 | n/a | n/a | -US$20m |
| Dec 31 2020 | US$896k | US$461k | -US$19m |
Compensation vs Market: Steve's total compensation ($USD7.01M) is above average for companies of similar size in the US market ($USD650.80K).
Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.
CEO
Steve Brady (54 yo)
3.4yrs
Tenure
US$7,007,407
Compensation
Mr. Stephen R. Brady, also known as Steve, LL M., J.D. served as an Independent Director at Atreca, Inc. since July 2021. He has been Chief Executive Officer & Director at Tempest Therapeutics Inc. since J...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.4yrs | US$7.01m | 0.17% $ 42.0k | |
| VP of Strategy & Finance and Secretary | 3.3yrs | US$1.32m | 0.033% $ 7.8k | |
| Executive VP & Chief Medical Officer | 4yrs | US$3.38m | 0.036% $ 8.7k | |
| Corporate Controller | 2.2yrs | no data | 0.083% $ 20.1k | |
| Head of Human Resources | less than a year | no data | no data |
3.3yrs
Average Tenure
48.5yo
Average Age
Experienced Management: TPST's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.4yrs | US$7.01m | 0.17% $ 42.0k | |
| Independent Director | 3.3yrs | US$67.34k | 0% $ 0 | |
| Independent Chairman | 5.5yrs | US$107.84k | 0% $ 0 | |
| Independent Director | 3.4yrs | US$65.12k | 0% $ 0 | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | 5.5yrs | no data | no data | |
| Independent Director | 3.3yrs | US$57.62k | 0% $ 0 | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | 3.2yrs | no data | no data |
3.4yrs
Average Tenure
59yo
Average Age
Experienced Board: TPST's board of directors are considered experienced (3.4 years average tenure).